Cerebrospinal Fluid Biomarkers for the Diagnosis of Prodromal Alzheimer's Disease in Amnestic Mild Cognitive Impairment

BACKGROUND/AIMS: Disease-modifying therapy for Alzheimer's disease (AD) has led to a need for biomarkers to identify prodromal AD and very early stage of AD dementia. We aimed to identify the cutoff values of cerebrospinal fluid (CSF) biomarkers for detecting prodromal AD. METHODS: We assessed...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Dement Geriatr Cogn Dis Extra
Auteurs principaux: Park, Jung Eun, Choi, Kyu Yeong, Kim, Byeong C., Choi, Seong-Min, Song, Min-Kyung, Lee, Jang Jae, Kim, Jahae, Song, Ho-Chun, Kim, Hoo-Won, Ha, Jung-Min, Seo, Eun Hyun, Song, Woo Keun, Park, Sung-Gyoo, Lee, Jung Sup, Lee, Kun Ho
Format: Artigo
Langue:Inglês
Publié: S. Karger AG 2019
Sujets:
Original Research Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6465729/
https://ncbi.nlm.nih.gov/pubmed/31011328
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000496920
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires